المؤلفون: Laval PA; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Piecyk M; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Guen PL; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Ilie MD; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Endocrinology Department, 'C.I.Parhon' National Institute of Endocrinology, Bucharest, Romania., Marion A; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Fauvre J; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Coste I; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Renno T; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Aznar N; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Hadji C; Cell&Soft, Grenoble, France., Migdal C; Cell&Soft, Grenoble, France., Duret C; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Bertolino P; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Ferraro-Peyret C; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Hospices Civils de Lyon, Plateforme AURAGEN, Lyon, France., Nicolas A; University Grenoble Alpes, CNRS, CEA/LETI Minatec, Grenoble Institute of Technology, Laboratory of Technology of Microelectronics, Grenoble, France., Chaveroux C; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France. Electronic address: cedric.chaveroux@lyon.unicancer.fr.

المصدر: Acta biomaterialia [Acta Biomater] 2024 Jul 01; Vol. 182, pp. 93-110. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568 (Electronic) Linking ISSN: 17427061 NLM ISO Abbreviation: Acta Biomater Subsets: MEDLINE

مواضيع طبية MeSH: Endoplasmic Reticulum Stress* , Extracellular Matrix*/metabolism, Humans ; Lung/metabolism ; Cell Differentiation ; Hydrogels/chemistry

المؤلفون: DE Alcubierre D; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon 1 University, Lyon, France., Carretti AL; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Department of Endocrinology, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Ducray F; Service of Neuro-Oncology, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Jouanneau E; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Department of Pituitary and Skull Base Neurosurgical, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Raverot G; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon 1 University, Lyon, France - gerald.raverot@chu-lyon.fr.; Department of Endocrinology, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Ilie MD; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Department of Endocrinology, C.I. Parhon National Institute of Endocrinology, Bucharest, Romania.

المصدر: Minerva endocrinology [Minerva Endocrinol (Torino)] 2024 Jan 19. Date of Electronic Publication: 2024 Jan 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Edizioni Minerva Medica Country of Publication: Italy NLM ID: 101777342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2724-6116 (Electronic) Linking ISSN: 27246116 NLM ISO Abbreviation: Minerva Endocrinol (Torino) Subsets: MEDLINE

المؤلفون: Ilie MD; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, 69008 Lyon, France.; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, 011863, Bucharest, Romania., Raverot G; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, 69008 Lyon, France.; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, 69500 Bron, France., Brac de la Perrière A; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, 69500 Bron, France.

المصدر: European journal of endocrinology [Eur J Endocrinol] 2024 Jan 03; Vol. 190 (1), pp. K17-K20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Acromegaly*/drug therapy , Human Growth Hormone*/therapeutic use, Humans ; Insulin-Like Growth Factor I/therapeutic use ; Somatostatin ; Glucose ; Treatment Outcome ; Octreotide/therapeutic use

المؤلفون: Ilie MD; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon, France; Lyon 1 University, Villeurbanne, France; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, Bucharest, Romania., De Alcubierre D; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon, France; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Carretti AL; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France., Jouanneau E; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon, France; Lyon 1 University, Villeurbanne, France; Neurosurgery Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France., Raverot G; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon, France; Lyon 1 University, Villeurbanne, France; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France. Electronic address: gerald.raverot@chu-lyon.fr.

المصدر: Pharmacology & therapeutics [Pharmacol Ther] 2023 Oct; Vol. 250, pp. 108506. Date of Electronic Publication: 2023 Aug 09.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors*/therapeutic use , Pituitary Neoplasms*/drug therapy, Humans ; Sunitinib/therapeutic use ; Tumor Microenvironment ; Bevacizumab ; Immunotherapy

المؤلفون: Ilie MD; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, Bucharest, Romania., Raverot G; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, Bucharest, Romania; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, 69677 Bron, France. Electronic address: gerald.raverot@chu-lyon.fr.

المصدر: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2023 Jul; Vol. 11 (7), pp. 442-443. Date of Electronic Publication: 2023 May 13.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Insipidus, Neurogenic* , Diabetes Insipidus*/complications , Diabetes Mellitus*, Humans ; Oxytocin ; Deamino Arginine Vasopressin ; Arginine

المؤلفون: Raymond P; Endocrinology Department, CHRU de Brabois, Vandoeuvre Les Nancy, France., Raverot G; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France.; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France., Ilie MD; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France.; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, Bucharest, Romania.

المصدر: Endocrine-related cancer [Endocr Relat Cancer] 2023 Mar 31; Vol. 30 (5). Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).

نوع المنشور: Systematic Review; Journal Article

بيانات الدورية: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Pituitary Neoplasms*/diagnosis , Pituitary Neoplasms*/therapy , Pituitary Neoplasms*/pathology, Humans ; Prognosis ; Ki-67 Antigen

المؤلفون: Ilie MD; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, 69373 Lyon, France.; Lyon 1 University, 69100 Villeurbanne, France.; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, 011684 Bucharest, Romania., Vasiljevic A; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, 69373 Lyon, France.; Lyon 1 University, 69100 Villeurbanne, France.; Pathology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, 69677 Bron, France., Bertolino P; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, 69373 Lyon, France., Raverot G; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, 69373 Lyon, France.; Lyon 1 University, 69100 Villeurbanne, France.; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, 69677 Bron, France.

المصدر: Endocrine reviews [Endocr Rev] 2023 Mar 04; Vol. 44 (2), pp. 297-311.

نوع المنشور: Review; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8006258 Publication Model: Print Cited Medium: Internet ISSN: 1945-7189 (Electronic) Linking ISSN: 0163769X NLM ISO Abbreviation: Endocr Rev Subsets: MEDLINE

مواضيع طبية MeSH: Pituitary Neoplasms*/drug therapy , Adenoma*/pathology , Adenoma*/radiotherapy, Humans ; Tumor Microenvironment

المؤلفون: Ziverec A; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France., Chanal M; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France., Raymond P; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France., Ilie MD; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France.; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, Bucharest, Romania., De Alcubierre D; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France., Pasternack A; Department of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Ritvos O; Department of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Raverot G; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France.; Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France.; Department of Endocrinology, Reference center for rare pituitary disease (HYPO), Groupement Hospitalier EST, Hospices Civils de Lyon, University of Lyon, Lyon, France., Bertolino P; Cancer Research Centre of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Claude Bernard University, Lyon, France.

المصدر: Endocrine-related cancer [Endocr Relat Cancer] 2023 Feb 03; Vol. 30 (3). Date of Electronic Publication: 2023 Feb 03 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Gonadotrophs*/metabolism , Pituitary Neoplasms*/metabolism, Mice ; Humans ; Animals ; Activins/metabolism ; Endothelial Cells/metabolism ; Follicle Stimulating Hormone, beta Subunit/metabolism ; Follicle Stimulating Hormone, beta Subunit/pharmacology ; Follicle Stimulating Hormone/metabolism ; Follicle Stimulating Hormone/pharmacology ; Pituitary Gland/metabolism ; Tumor Microenvironment

المؤلفون: Lepetit M; ENS de Lyon, CNRS UMR 5239, Laboratory of Biology and Modelling of the Cell, Lyon, France., Ilie MD; Centre de Recherche en Cancérologie (CRCL) - INSERM 1052 - CNRS 5286 - Centre Léon Bérard - Université Claude Bernard Lyon 1, Institut Convergence Plascan, Lyon, France.; Endocrinology Department, 'C.I.Parhon' National Institute of Endocrinology, Bucharest, Romania., Chanal M; Centre de Recherche en Cancérologie (CRCL) - INSERM 1052 - CNRS 5286 - Centre Léon Bérard - Université Claude Bernard Lyon 1, Institut Convergence Plascan, Lyon, France., Raverot G; Centre de Recherche en Cancérologie (CRCL) - INSERM 1052 - CNRS 5286 - Centre Léon Bérard - Université Claude Bernard Lyon 1, Institut Convergence Plascan, Lyon, France.; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France., Bertolino P; Centre de Recherche en Cancérologie (CRCL) - INSERM 1052 - CNRS 5286 - Centre Léon Bérard - Université Claude Bernard Lyon 1, Institut Convergence Plascan, Lyon, France., Arpin C; ENS de Lyon, CNRS UMR 5239, Laboratory of Biology and Modelling of the Cell, Lyon, France., Picard F; ENS de Lyon, CNRS UMR 5239, Laboratory of Biology and Modelling of the Cell, Lyon, France., Gandrillon O; ENS de Lyon, CNRS UMR 5239, Laboratory of Biology and Modelling of the Cell, Lyon, France.; Inria Center Grenoble Rhone-Alpes, Equipe Dracula, Villeurbanne, France.

المصدر: In silico biology [In Silico Biol] 2023; Vol. 15 (1-2), pp. 11-21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9815902 Publication Model: Print Cited Medium: Internet ISSN: 1434-3207 (Electronic) Linking ISSN: 13866338 NLM ISO Abbreviation: In Silico Biol Subsets: MEDLINE

مواضيع طبية MeSH: RNA-Seq* , Single-Cell Gene Expression Analysis* , Software*, Datasets as Topic ; Humans ; Animals ; Mice ; Pituitary Neoplasms/genetics ; CD8-Positive T-Lymphocytes ; Gene Expression Profiling ; Computational Biology ; Workflow

المؤلفون: Raverot G; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France. Electronic address: gerald.raverot@chu-lyon.fr., Ilie MD; Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France; Endocrinology Department, 'C.I. Parhon' National Institute of Endocrinology, Bucharest, Romania. Electronic address: mireladiana.ilie@gmail.com.

المصدر: Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2022 Dec; Vol. 36 (6), pp. 101712. Date of Electronic Publication: 2022 Oct 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120682 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1594 (Electronic) Linking ISSN: 1521690X NLM ISO Abbreviation: Best Pract Res Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Pituitary Neoplasms*/drug therapy , Pituitary Neoplasms*/genetics, Humans ; Mutation ; Immunotherapy/methods ; Microsatellite Instability ; Biomarkers, Tumor ; Temozolomide/therapeutic use